Pharmacological Primary Prevention of Diabetes Mellitus Type II: A Narrative Review

被引：5

作者：

Naveed, Ali ^{[1
,2
]}

Farrukh, Larabe ^{[1
,2
]}

Sana, Muhammad Khawar ^{[1
,2
]}

Naveed, Bazigh ^{[1
,2
]}

Randhawa, Fawad Ahmad ^{[2
,3
]}

机构：

[1] King Edward Med Univ, Internal Med, Lahore, Pakistan

[2] Mayo Hosp, Lahore, Pakistan

[3] King Edward Med Univ, Diabet & Endocrinol, Lahore, Pakistan

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 08期

关键词：

primary prevention; pharmacological prevention; diabetes mellitus type ii; pre-diabetes; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE MODIFICATION; METABOLIC SYNDROME; FASTING GLUCOSE; HIGH-RISK; ACARBOSE; ROSIGLITAZONE; COMPLICATIONS; INDIVIDUALS; LIRAGLUTIDE;

D O I：

10.7759/cureus.10033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The evolving epidemic of type 2 diabetes mellitus has challenged health-care professionals. It stands among the leading causes of mortality in the present world. It warrants new and versatile approaches to improve mortality and the associated huge quality-adjusted life years lost to it once diagnosed. A possible venue to lower the incidence is to assess the safety and efficacy of various diabetes prevention strategies. Diet and exercise have a well-developed role in the prevention of weight gain and, ultimately, diabetes mellitus type II in high-risk individuals. However, high-risk individuals can also benefit from adjunct pharmacotherapy. In light of this information, we decided to conduct a systematic review of randomized controlled trials. This article summarizes the evidence in the literature on the pharmacological prevention of diabetes in high-risk individuals.

引用

页数：11

共 40 条

[1] Mechanism linking diabetes mellitus and obesity [J].

Al-Goblan, Abdullah S. ;

Al-Alfi, Mohammed A. ;

Khan, Muhammad Z. .

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 :587-591

[2] Effects of Different Dietary and Lifestyle Modification Therapies on Metabolic Syndrome in Prediabetic Arab Patients: A 12-Month Longitudinal Study [J].

Alfawaz, Hanan A. ;

Wani, Kaiser ;

Alnaami, Abdullah M. ;

Al-Saleh, Yousef ;

Aljohani, Naji J. ;

Al-Attas, Omar S. ;

Alokail, Majed S. ;

Kumar, Sudhesh ;

Al-Daghri, Nasser M. .

NUTRIENTS, 2018, 10 (03)

[3] Effect of liraglutide administration and a calorie-restricted diet on lipoprotein profile in overweight/obese persons with prediabetes [J].

Ariel, D. ;

Kim, S. H. ;

Abbasi, F. ;

Lamendola, C. A. ;

Liu, A. ;

Reaven, G. M. .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (12) :1317-1322

[4] Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].

Buchanan, TA ;

Xiang, AH ;

Peters, RK ;

Kjos, SL ;

Marroquin, A ;

Goico, J ;

Ochoa, C ;

Tan, S ;

Berkowitz, K ;

Hodis, HN ;

Azen, SP .

DIABETES, 2002, 51 (09) :2796-2803

[5]

Centers for Disease Control and Prevention, 2020, EST DIAB ITS BURD US

[6] Determinants of Sedentary Behavior, Motivation, Barriers and Strategies to Reduce Sitting Time in Older Women: A Qualitative Investigation [J].

Chastin, Sebastien F. M. ;

Fitzpatrick, Nicole ;

Andrews, Michelle ;

DiCroce, Natalie .

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2014, 11 (01) :773-791

[7] Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].

Chiasson, JL ;

Josse, RG ;

Gomis, R ;

Hanefeld, M ;

Karasik, A ;

Laakso, M .

LANCET, 2002, 359 (9323) :2072-2077

[8]

Chong Shanley, 2017, Diabetes Spectr, V30, P43, DOI 10.2337/ds15-0044

[9] Insulin action and resistance in obesity and type 2 diabetes [J].

Czech, Michael P. .

NATURE MEDICINE, 2017, 23 (07) :804-814

[10] Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance [J].

Durbin, RJ .

DIABETES OBESITY & METABOLISM, 2004, 6 (04) :280-285

← 1 2 3 4 →